Cycloset Tablet
Product Images NDC 73515-123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cycloset (NDC 73515-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avvisto Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cycloset 01)

Chemical Structure (Cycloset 01)
Chemical structure diagram of bromocriptine mesylate, the active ingredient in CYCLOSET tablets, illustrating its molecular configuration with labeled atoms and bonds.*
FDA Label Image

Principal Display Panel (0.8 mg Tablet Bottle Label)

Principal Display Panel (0.8 mg Tablet Bottle Label)
CYCLOSET bromocriptine mesylate tablets 0.8 mg label for a 200-tablet bottle. The label includes the NDC 73515-123-30, dosage strength, manufacturer information for VeroScience LLC, and distributor Avwisto Therapeutics LLC. It also contains usage and storage instructions, a barcode, and states the product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.